Search hospitals > Illinois > Ottawa
Illinois CancerCare-Ottawa Clinic
Claim this profileOttawa, Illinois 61350
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Stomach Cancer
416 reported clinical trials
22 medical researchers
Summary
Illinois CancerCare-Ottawa Clinic is a medical facility located in Ottawa, Illinois. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Stomach Cancer and other specialties. Illinois CancerCare-Ottawa Clinic is involved with conducting 416 clinical trials across 553 conditions. There are 22 research doctors associated with this hospital, such as Bryan A. Faller, John Hilton, MD, James L. Wade, and Johanne Weberpals, MD.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Bryan A. FallerCrossroads Cancer Center6 years of reported clinical research
Expert in Skin Cancer
Expert in Lung Cancer
239 reported clinical trials
296 drugs studied
John Hilton, MDOttawa Hospital Research Institute8 years of reported clinical research
Studies Breast Cancer
Studies Tumors
13 reported clinical trials
34 drugs studied
James L. WadeDecatur Memorial Hospital4 years of reported clinical research
Studies Relapse
Studies Breast Cancer
11 reported clinical trials
20 drugs studied
Johanne Weberpals, MDThe Ottawa Hospital Cancer Centre5 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
7 reported clinical trials
17 drugs studied
Clinical Trials running at Illinois CancerCare-Ottawa Clinic
Breast Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Breast cancer
Multiple Myeloma
Ovarian Cancer
Non-Small Cell Lung Cancer
Stomach Cancer
Esophageal Adenocarcinoma
Shorter HER2-targeted Therapy
for Breast Cancer
This trial tests if a shorter treatment period is effective for early-stage, HER2-positive breast cancer patients who have responded well to initial treatment. The aim is to reduce side effects and costs while maintaining treatment effectiveness. For many years, a longer treatment period has been the standard for these patients.
Recruiting3 awards Phase 43 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Illinois CancerCare-Ottawa Clinic?
Illinois CancerCare-Ottawa Clinic is a medical facility located in Ottawa, Illinois. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Stomach Cancer and other specialties. Illinois CancerCare-Ottawa Clinic is involved with conducting 416 clinical trials across 553 conditions. There are 22 research doctors associated with this hospital, such as Bryan A. Faller, John Hilton, MD, James L. Wade, and Johanne Weberpals, MD.
Where is Illinois CancerCare-Ottawa Clinic located?
The Illinois CancerCare-Ottawa Clinic is located at 1200 Starfire Drive, Ottawa, IL 61350, conveniently accessible off I-80 for patients in the area.
Who should I call to ask about financial aid or insurance network?
For financial assistance and billing inquiries at Illinois CancerCare-Ottawa Clinic, patients can use the general contact number (217) 383-3311. For more detailed billing questions, the Central Business Office can be reached at (847) 585-7000. It is advisable to contact the clinic directly for specific departmental information.
What insurance does Illinois CancerCare-Ottawa Clinic accept?
The Illinois CancerCare-Ottawa Clinic accepts a wide range of insurance plans, including but not limited to Medicare, Aetna (HMO, PPO, POS), BCBS of Illinois (PPO, POS, EPO, Classic Blue HMO, HMOI, Blue Advantage HMO), Beech Street PPO, Cigna/Great West Healthcare (HMO, PPO, POS, Open Access), and United Health Care. Additionally, they accept CorVel, Coventry/First Health/Personal Care, Evolutions, Galaxy, Health Dynamics, Healthlink PPO, HFN PPO, Humana (HMO, PPO Choice POS, Choice Care Network), Multiplan, National Provider Network, PHCS, PHCS Savility PPO, PNA, Preferred Plan, Three Rivers Provider Network. It's recommended to contact the clinic directly to confirm if your specific insurance plan is accepted.
What awards or recognition has Illinois CancerCare-Ottawa Clinic received?
Illinois CancerCare-Ottawa Clinic, located in Ottawa, Illinois, is renowned for its dedication to cancer research and quality care. It has earned the Quality Oncology Practice Initiative (QOPI®) Certification, signifying its adherence to the highest national standards for outpatient hematology-oncology practices. Furthermore, the clinic is celebrated by the Alliance for Clinical Trials in Oncology for being among the top enrollers in clinical research, demonstrating its commitment to pioneering new cancer treatments through clinical trials.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.